8-K: MetLife Q3 2025 Adjusted Earnings Soar 15% on Strong VII

MetLife reports a robust third quarter 2025 with adjusted earnings up 15% and adjusted EPS ex. notable items rising 21%, driven by higher variable investment income and volume growth.

Summary

• Net income was $818 million, or $1.22 per share, a decrease of 36% compared to the prior year quarter.
• Adjusted earnings increased 15% to $1.6 billion, or $2.37 per share, primarily driven by higher variable investment income and volume growth.
• Adjusted earnings per share, excluding total notable items, rose 21% to $2.34.
• Premiums, fees and other revenues (PFOs) were $12.5 billion, flat compared to the prior year quarter.
• Adjusted PFOs, excluding pension risk transfers (PRT), increased 4% to $12.5 billion, with growth in all segments except MetLife Holdings.
• Net investment income was $6.1 billion, up 16%, primarily due to increases in the estimated fair value of certain securities.
• Variable investment income (VII) was $483 million, reflecting higher private equity returns and above quarterly guidance.
• Book value per share (BVPS) increased 1% to $39.52, and adjusted BVPS increased 3% to $56.57.
• Approximately $875 million was returned to shareholders via share repurchases and common stock dividends in the quarter.
• Holding company cash and liquid assets totaled $4.9 billion at quarter end, within the target cash buffer of $3.0 to $4.0 billion.
• Secured $12 billion in PRT mandates in the fourth quarter to-date.
• Asia sales grew 34% on a constant currency basis, with Japan up 31% and Other Asia sales up 39%.
• Latin America adjusted earnings decreased 33% (34% on a constant currency basis) due to a $71 million after-tax charge related to a tax matter in Mexico.
• The direct expense ratio, excluding total notable items related to direct expenses and PRT, was 11.6%, which is below the 12.1% annual target.
• The annual actuarial assumption review and other insurance adjustments positively impacted net income by $102 million and adjusted earnings by $89 million.

Sentiment

Score: 8

Explanation: The filing reports strong adjusted earnings and EPS growth, significant variable investment income, successful capital return to shareholders, and positive sales momentum in key international segments. While net income declined due to market volatility, the underlying business performance, as reflected in adjusted metrics, is robust. The tax charge in Latin America is a notable item but does not overshadow the overall positive operational results and strategic progress.

Positives

• Adjusted earnings increased 15% to $1.6 billion, demonstrating strong operational performance.
• Adjusted earnings per share, excluding total notable items, increased 21% to $2.34.
• Adjusted premiums, fees and other revenues, excluding pension risk transfers (PRT), grew 4% to $12.5 billion, with broad-based volume growth across most segments.
• Net investment income increased 16% to $6.1 billion, driven by higher estimated fair value of certain securities.
• Variable investment income was $483 million, significantly above guidance due to higher private equity returns.
• Book value per share (BVPS) increased 1% to $39.52, and adjusted BVPS increased 3% to $56.57.
• Approximately $875 million was returned to shareholders in 3Q25 through $500 million in share repurchases and $375 million in common stock dividends.
• Holding company cash and liquid assets of $4.9 billion at quarter-end are within the target cash buffer of $3.0 billion to $4.0 billion.
• Solid Group Benefits underwriting was delivered, including a 230-basis point sequential improvement in the non-medical health loss ratio.
• Secured $12 billion in PRT mandates in the fourth quarter to-date, indicating strong future business generation.
• Asia sales grew 34% on a constant currency basis, with Japan up 31% and Other Asia sales up 39%, reflecting new retirement-oriented products.
• MetLife Xcelerator was expanded in Latin America through a new partnership with Mercado Libre in Brazil and Mexico.
• The direct expense ratio, excluding total notable items related to direct expenses and PRT, was 11.6%, which is below the 12.1% annual target.
• The annual actuarial assumption review and other insurance adjustments positively impacted net income by $102 million and adjusted earnings by $89 million.
• Expected total U.S. Statutory Adjusted Capital on an NAIC basis is approximately $17.1 billion at September 30, 2025, flat from June 30, 2025.
• The expected Japan Solvency Margin ratio is 740% at September 30, 2025.
• The estimated Economic Solvency Ratio is 170% to 190% for the period ending March 2026.
• The commercial mortgage loans (CML) portfolio is high quality, with a 69% average Loan-to-Value (LTV) Ratio and 2.1x average Debt Service Coverage Ratio (DSCR).

Negatives

• Net income decreased 36% to $818 million, or $1.22 per share, primarily due to higher net derivative losses and net investment losses.
• Net derivative losses amounted to $929 million ($734 million after tax), attributed to stronger equity markets, higher long-term interest rates, and a strengthening U.S. dollar.
• Net investment losses were $325 million ($257 million after tax), reflecting normal trading activity.
• Latin America adjusted earnings decreased 33% on a reported basis (34% constant currency) due to a $71 million after-tax charge related to the resolution of an industry-wide tax matter in Mexico.
• The Corporate & Other segment reported an adjusted loss of $288 million, compared to $249 million in the prior year, primarily due to elevated expenses from market-related employee costs and higher interest payments on outstanding debt.
• Adjusted PFOs for MetLife Holdings were down 8% to $729 million, largely due to the continued run-off of the business.

Risks

• Economic condition difficulties, including risks relating to interest rates, the effects of announced or future tariff increases on the global economy, credit spreads, declining equity or debt markets, real estate, obligors and counterparties, government default or shutdown, currency exchange rates, derivatives, climate change, public health, terrorism and security.
• Global capital and credit market adversity.
• Credit facility inaccessibility.
• Financial strength or credit ratings downgrades.
• Unavailability, unaffordability, or inadequate reinsurance, including reinsurance risks that arise from reinsurers' credit risk, and the potential shortfall or failure of risk mitigants to protect against such risks.
• Statutory life insurance reserve financing costs or limited market capacity.
• Legal, regulatory, and supervisory and enforcement policy changes.
• Changes in tax rates, tax laws or interpretations.
• Litigation and regulatory investigations.
• Unsuccessful efforts to meet all environmental, social, and governance standards or to enhance sustainability.
• Inability to pay dividends and repurchase common stock.
• MetLife's subsidiaries' inability to pay dividends to MetLife, Inc.
• Investment defaults, downgrades, or volatility.
• Investment sales or lending difficulties.
• Collateral or derivative-related payments.
• Investment valuations, allowances, or impairments changes.
• Claims or other results that differ from estimates, assumptions, or models.
• Global political, legal, or operational risks.
• Business competition.
• Technological changes.
• Catastrophes.
• Climate changes or responses to it.
• Deficiencies in the closed block.
• Goodwill or other asset impairment, or deferred income tax asset allowance.
• Impairment of VOBA, value of distribution agreements acquired or value of customer relationships acquired.
• Product guarantee volatility, costs, and counterparty risks.
• Risk management failures.
• Insufficient protection from operational risks.
• Failure to protect confidentiality, integrity or availability of systems or data or other cybersecurity or disaster recovery failures.
• Accounting standards changes.
• Excessive risk-taking.
• Marketing and distribution difficulties.
• Pension and other postretirement benefit assumption changes.
• Inability to protect intellectual property or avoid infringement claims.
• Acquisition, integration, growth, disposition, or reorganization difficulties.
• Brighthouse Financial, Inc. separation risks.
• MetLife, Inc.'s Board of Directors influence over the outcome of stockholder votes through the voting provisions of the MetLife Policyholder Trust.
• Legaland corporate governance-related effects on business combinations.

Future Outlook

MetLife anticipates continued momentum into year-end, having already secured $12 billion in pension risk transfer mandates in the fourth quarter to date. The company expects to expand its reach and enhance access to insurance and retirement solutions through strategic partnerships. The estimated Economic Solvency Ratio is projected to be between 170% and 190% for the period ending March 2026.

Management Comments

• "MetLife delivered an excellent third quarter that reinforces the strength of our diversified business model and disciplined execution of our New Frontier strategy."
• "Adjusted earnings per share, excluding total notable items, grew 21% year-over-year, driven by strong variable investment income, broad-based volume growth, and diligent expense management."
• "Momentum continues to build as we head into year-end. We've secured $12 billion in PRT mandates in the fourth quarter to-date and launched strategic partnerships that will expand our reach and enhance access to our insurance and retirement solutions."
• "These results demonstrate MetLife's earnings power and our ability to deliver all-weather performance – driving responsible growth and high returns for shareholders today and in the future."

Industry Context

MetLife's strong performance, particularly in adjusted earnings and sales growth in Asia and Latin America, indicates effective navigation of diverse global markets. The significant increase in variable investment income, driven by private equity returns, aligns with broader trends of strong alternative asset performance in the financial sector. The securing of substantial pension risk transfer mandates reflects a robust market for de-risking solutions, a key area for life insurers. The expansion of MetLife Xcelerator through partnerships like Mercado Libre highlights a strategic focus on digital distribution and broader market access, a common theme among leading financial services companies adapting to evolving customer preferences.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: Positive impact due to increased adjusted earnings, adjusted EPS, share repurchases ($500 million in 3Q25, $2.6 billion YTD through Oct 2025), and common stock dividends ($375 million in 3Q25).
• Customers: Enhanced access to insurance and retirement solutions through strategic partnerships (e.g., Mercado Libre in Brazil and Mexico).
• Employees: Market-related employee costs contributed to elevated expenses in Corporate & Other.

Next Steps

• MetLife will hold its third quarter 2025 earnings conference call and audio webcast on Thursday, November 6, 2025, from 9-10 a.m. (ET).
• Continue building momentum into year-end.
• Expand reach and enhance access to insurance and retirement solutions through strategic partnerships.
• Monitor Economic Solvency Ratio for the period ending March 2026.

Key Dates

Recommendation

The filing demonstrates robust underlying business performance with a 15% increase in adjusted earnings and a 21% rise in adjusted EPS, excluding notable items. Key drivers include strong variable investment income from private equity and broad-based volume growth across segments, particularly in Asia and Latin America. The company's disciplined expense management, evidenced by a direct expense ratio below target, and significant capital return to shareholders ($875 million in Q3) are highly attractive. The $12 billion in Q4 pension risk transfer mandates signals continued strong business development. While GAAP net income was impacted by market volatility, the adjusted metrics provide a clearer picture of operational strength and future potential, making it a strong buy for long-term investors.

Keywords

MetLife, MET, Earnings, Q3 2025, Financial Results, Insurance, Annuities, Employee Benefits, Asset Management, Adjusted Earnings, EPS, Variable Investment Income, Pension Risk Transfers, Actuarial Review, Capital, Solvency, Commercial Mortgage Loans, Share Repurchases, Dividends